The results of previous study analyzing genetic alterations across various sarcoma types through targeted sequencing to identify effective targeted agents revealed that the most prevalent targetable changes involved cell cycle control, TP53, receptor tyrosine kinase/PI3K/RAS pathways, and epigenetic regulators (31). The gene discussed is TP53; the disease is sarcoma.